Comments
Loading...
Lyra Therapeutics (LYRA) Forecast
NewsEarningsLyra Therapeutics (LYRA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLyra Therapeutics (NASDAQ:LYRA) Stock Quotes, Forecast and News Summary
Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lyra Therapeutics (LYRA) stock?
You can purchase shares of Lyra Therapeutics (NASDAQ:LYRA) through any online brokerage.
Who are Lyra Therapeutics (LYRA) competitors?
Other companies in Lyra Therapeutics’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
What is the forecast, or price target, for Lyra Therapeutics (LYRA) stock?
Lyra Therapeutics has a consensus price target of $8.38.
What is the current price for Lyra Therapeutics (LYRA)?
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $0.171 last updated November 18, 2024 at 9:25 AM EST.
Does Lyra Therapeutics (LYRA) pay a dividend?
There are no upcoming dividends for Lyra Therapeutics.
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Lyra Therapeutics (LYRA) going to split?
There is no upcoming split for Lyra Therapeutics.
What sector and industry does Lyra Therapeutics (LYRA) operate in?
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.